NEW YORK--(BUSINESS WIRE)--Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), BlackRock Enhanced International Dividend Trust (NYSE: BGY), BlackRock Health Sciences Trust (NYSE: BME), BlackRock Health Sciences Term Trust (NYSE: BMEZ), BlackRock Enhanced Global Dividend Trust (NYSE: BOE), BlackRock Utilities, Infrastructure & Power Opportunities Trust (NYSE: BUI), BlackRock Enhanced Large Cap Core Fund, Inc. (NYSE: CII), BlackRock Science and Technology Trust (NYSE: BST), BlackRock Science and Technology Term Trust (NYSE: BSTZ), BlackRock Technology and Private Equity Term Trust (NYSE: BTX), BlackRock Capital Allocation Term Trust (NYSE: BCAT), and BlackRock ESG Capital Allocation Term Trust (NYSE: ECAT) (collectively, the “Funds”) paid the following distributions per share:
BlackRock Technology and Private Equity Term Trust(BTX)Earnings, Financials & Key Ratios
BTX•NASDAQ
$8.44
49.6× P/E·Price updated Jul 7, 2026
AboutBlackRock Innovation and Growth Trust (the Trust) is a newly-organized, non-diversified, closed-end management investment company with no operating history. The Trusts investment objectives are to provide total return and income through a combination of current income, current gains and long-term capital appreciation. There can be no assurance that the Trusts investment objectives will be achieved or that the Trusts investment program will be successful The Trust will invest primarily in equity securities issued by mid- and small-capitalization companies that the Trusts adviser believes have above-average earnings growth potential. In selecting investments for the Trust, the Trusts adviser focuses on mid- and small-capitalization growth companies that are innovative. These are companies that have introduced, or are seeking to introduce, a new product or service that potentially changes the marketplace.Show more
- Revenue$41M-81.1%
- EBITDA$36M-83.1%
- Net Income$36M-83.1%
- EPS (Diluted)0.17-82.7%
- Gross Margin100%
- EBITDA Margin87.75%-10.6%
- Operating Margin87.75%-10.6%
- Net Margin87.75%-10.6%
- ROE1.87%-82.1%
BTX Price & Volume
BlackRock Technology and Private Equity Term Trust (BTX) stock price & volume — 10-year historical chart
Loading chart...
Stalled Realizations Pressure Net Asset Value Sustainability
Investment Thesis • Updated N/A
VerdictNegative
Growth:Contracting
Profitability:Strained
Financial:Mixed
Cash Flow:Deteriorating
Primary Risk:NAV discount and liquidity
Key Thesis Takeaways
- BTX faces significant headwinds as the 81.13% year-over-year revenue decline highlights a stalled investment realization cycle within its private biotechnology portfolio.
- The trust's reliance on Level 3 asset valuations, coupled with a 9.8% dividend yield that may be funded by Return of Capital, suggests a disconnect between reported distributions and actual economic earnings.
- Investors should monitor the persistent discount to NAV, which appears to reflect market skepticism regarding the carrying value of private holdings in a high-interest-rate environment.
Verdict Logic
the combination of an 81.13% revenue decline and the structural risk that distributions are funded by Return of Capital rather than genuine earnings warrants extreme caution for income-focused investors.
BTX Growth Metrics
BlackRock Technology and Private Equity Term Trust (BTX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM-
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-
Return on Capital
10 Years-14.14%
5 Years-14.14%
3 Years-14.14%
Last Year1.84%
Latest BTX News
Recent stock market news and headlines for BlackRock Technology and Private Equity Term Trust (BTX)
Business Wire·Jun 30, 2026
Certain BlackRock Closed-End Funds Announce Estimated Sources of DistributionsPeers Comparison
Key metrics vs top competitors for BlackRock Technology and Private Equity Term Trust (BTX)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $8.44 | $985.03M | 49.65 | -81.13% | 87.75% | 1.87% | 10.14% | |
| $12.75 | $3.32B | 8.98 | 42.5% | 26.91% | 5.24% | — | |
| $15.99 | $2.99B | 8.64 | 26.97% | 50.05% | 13.18% | — | |
| $4.75 | $192.85M | 3.89 | 36.55% | -19.55% | -3.39% | — | |
| $9.00 | $1.01B | 8.74 | 26% | 25.87% | 5.14% | — | |
| $1009.43 | $156.46B | 28.50 | 18.67% | 24.4% | 10.5% | — |
Compare BTX vs Peers
BlackRock Technology and Private Equity Term Trust (BTX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when BTX posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
BTX Frequently Asked Questions
BlackRock Technology and Private Equity Term Trust (BTX) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is BlackRock Technology and Private Equity Term Trust's revenue?
BlackRock Technology and Private Equity Term Trust (BTX) reported $40.7M in revenue for fiscal year 2024.
How fast is BlackRock Technology and Private Equity Term Trust growing?
BlackRock Technology and Private Equity Term Trust (BTX) saw revenue decline by 81.1% over the past year.
Is BTX profitable?
Yes, BlackRock Technology and Private Equity Term Trust (BTX) is profitable, generating $35.7M in net income for fiscal year 2024 (87.7% net margin).
Dividend & Returns
Does BTX pay dividends?
Yes, BlackRock Technology and Private Equity Term Trust (BTX) pays a dividend with a yield of 10.14%. This makes it attractive for income-focused investors.
What is BTX's return on equity?
BlackRock Technology and Private Equity Term Trust (BTX) has a return on equity (ROE) of 1.9%. This is below average, suggesting room for improvement.
What is BlackRock Technology and Private Equity Term Trust's free cash flow?
BlackRock Technology and Private Equity Term Trust (BTX) generated $277.2M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.